CN104897839A - 一种多组分综合量化的中药质量评控方法及应用 - Google Patents
一种多组分综合量化的中药质量评控方法及应用 Download PDFInfo
- Publication number
- CN104897839A CN104897839A CN201510324220.4A CN201510324220A CN104897839A CN 104897839 A CN104897839 A CN 104897839A CN 201510324220 A CN201510324220 A CN 201510324220A CN 104897839 A CN104897839 A CN 104897839A
- Authority
- CN
- China
- Prior art keywords
- content
- active component
- medicinal material
- represent
- rhubarb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 88
- 238000000034 method Methods 0.000 title claims abstract description 34
- 240000001745 Rheum palmatum Species 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims description 89
- 241000219061 Rheum Species 0.000 claims description 86
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 86
- 239000000463 material Substances 0.000 claims description 85
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 81
- IPQVTOJGNYVQEO-CXZNLNCXSA-N sennoside A Natural products O=C(O)c1cc(O)c2C(=O)c3c(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O4)cccc3[C@@H]([C@H]3c4c(c(O)cc(C(=O)O)c4)C(=O)c4c(O[C@H]5[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O5)cccc34)c2c1 IPQVTOJGNYVQEO-CXZNLNCXSA-N 0.000 claims description 53
- 229930182470 glycoside Natural products 0.000 claims description 52
- 240000004980 Rheum officinale Species 0.000 claims description 45
- 235000008081 Rheum officinale Nutrition 0.000 claims description 43
- 239000000243 solution Substances 0.000 claims description 40
- 239000013558 reference substance Substances 0.000 claims description 37
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 claims description 36
- 238000012360 testing method Methods 0.000 claims description 31
- 239000012071 phase Substances 0.000 claims description 22
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 claims description 20
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 claims description 18
- IPQVTOJGNYVQEO-AIFLABODSA-N sennoside B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-AIFLABODSA-N 0.000 claims description 18
- 229940004991 sennoside b Drugs 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 17
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 claims description 10
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 claims description 10
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 8
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 8
- 239000010452 phosphate Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 238000010812 external standard method Methods 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 4
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 241000205407 Polygonum Species 0.000 claims description 2
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 7
- 238000005259 measurement Methods 0.000 abstract description 5
- 235000008090 Rheum palmatum Nutrition 0.000 abstract 3
- 235000008216 herbs Nutrition 0.000 abstract 2
- 230000001543 purgative effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 9
- 206010010774 Constipation Diseases 0.000 description 7
- 238000004448 titration Methods 0.000 description 7
- 239000003643 water by type Substances 0.000 description 7
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 6
- 150000004056 anthraquinones Chemical class 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 238000004166 bioassay Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- -1 compound diphenoxylate Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 229940039750 aconitine Drugs 0.000 description 2
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229960004192 diphenoxylate Drugs 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000005291 Rumex acetosa Nutrition 0.000 description 1
- 240000007001 Rumex acetosella Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MGRRGKWPEVFJSH-UHFFFAOYSA-N dianthrone Natural products C12=CC=CC=C2C(=O)C2=CC=CC=C2C1=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MGRRGKWPEVFJSH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- GQRPJUIKGLHLLN-VSTHTWNCSA-N mesaconine Chemical compound COC[C@]12CN(C)C3[C@@H]4[C@H](OC)[C@H]1[C@]3([C@@H]1C[C@@]3(O)[C@H](O)[C@@H]1[C@]4(O)[C@@H](O)[C@@H]3OC)[C@H](C[C@H]2O)OC GQRPJUIKGLHLLN-VSTHTWNCSA-N 0.000 description 1
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 description 1
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 229930186851 sennoside Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000003513 sheep sorrel Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510324220.4A CN104897839B (zh) | 2015-06-12 | 2015-06-12 | 一种多组分综合量化的中药质量评控方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510324220.4A CN104897839B (zh) | 2015-06-12 | 2015-06-12 | 一种多组分综合量化的中药质量评控方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104897839A true CN104897839A (zh) | 2015-09-09 |
CN104897839B CN104897839B (zh) | 2017-02-08 |
Family
ID=54030632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510324220.4A Active CN104897839B (zh) | 2015-06-12 | 2015-06-12 | 一种多组分综合量化的中药质量评控方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104897839B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019100952A1 (zh) * | 2017-11-21 | 2019-05-31 | 石家庄以岭药业股份有限公司 | 一种中药组合物的生物检测方法 |
CN113009047A (zh) * | 2021-04-12 | 2021-06-22 | 湖北一正药业股份有限公司 | 一种中药复方饮片质量管理监督方法 |
CN114636779A (zh) * | 2022-03-29 | 2022-06-17 | 陕西科技大学 | 三化汤基准样品冻干粉指纹图谱的构建方法及其指纹图谱 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0928781A1 (en) * | 1997-12-30 | 1999-07-14 | Laboratoire Medidom S.A. | Process for the preparation of rhein and its diacyl derivatives |
CN101590128A (zh) * | 2009-06-12 | 2009-12-02 | 刘斌 | 一种基于调脂抗氧化效应的降脂宁质量评价方法 |
CN103352069A (zh) * | 2013-07-03 | 2013-10-16 | 中国人民解放军第三〇二医院 | 一种用于何首乌及其中药制剂肝毒性评价的生物毒性效价检定方法 |
CN103969352A (zh) * | 2013-02-02 | 2014-08-06 | 西安世纪盛康药业有限公司 | 一种大黄药材的指纹图谱的鉴别方法 |
-
2015
- 2015-06-12 CN CN201510324220.4A patent/CN104897839B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0928781A1 (en) * | 1997-12-30 | 1999-07-14 | Laboratoire Medidom S.A. | Process for the preparation of rhein and its diacyl derivatives |
CN101590128A (zh) * | 2009-06-12 | 2009-12-02 | 刘斌 | 一种基于调脂抗氧化效应的降脂宁质量评价方法 |
CN103969352A (zh) * | 2013-02-02 | 2014-08-06 | 西安世纪盛康药业有限公司 | 一种大黄药材的指纹图谱的鉴别方法 |
CN103352069A (zh) * | 2013-07-03 | 2013-10-16 | 中国人民解放军第三〇二医院 | 一种用于何首乌及其中药制剂肝毒性评价的生物毒性效价检定方法 |
Non-Patent Citations (5)
Title |
---|
WEI LI 等: "Methodological research on the quality evaluation of Radix Isatidis based on antibacterial potency", 《WORLD SCIENCE AND TECHNOLOGY》 * |
YIN XIONG 等: "Biopotency Assays: an Integrated Application to Quality Control of Chinese Materia Medica", 《CHINESE HERBAL MEDICINES》 * |
李会芳 等: "致泻效价检测用于大黄品质评价的方法研究", 《中国中药杂志》 * |
熊吟 等: "综合量化集成的中药品质评控策略:中药效应成分指数", 《中草药》 * |
王伽伯 等: "基于化学分析的大黄药材商品规格划分的科学合理性研究", 《中国中药杂质》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019100952A1 (zh) * | 2017-11-21 | 2019-05-31 | 石家庄以岭药业股份有限公司 | 一种中药组合物的生物检测方法 |
CN113009047A (zh) * | 2021-04-12 | 2021-06-22 | 湖北一正药业股份有限公司 | 一种中药复方饮片质量管理监督方法 |
CN114636779A (zh) * | 2022-03-29 | 2022-06-17 | 陕西科技大学 | 三化汤基准样品冻干粉指纹图谱的构建方法及其指纹图谱 |
CN114636779B (zh) * | 2022-03-29 | 2024-05-24 | 陕西盘龙药业集团股份有限公司 | 三化汤基准样品冻干粉指纹图谱的构建方法及其指纹图谱 |
Also Published As
Publication number | Publication date |
---|---|
CN104897839B (zh) | 2017-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988526B (zh) | 一种白灵片的制备方法及应用 | |
CN101744948B (zh) | 一种油茶蒲提取物及其制备方法和用途 | |
CN104897839A (zh) | 一种多组分综合量化的中药质量评控方法及应用 | |
Wang et al. | Negative pressure cavitation based ultrasound-assisted extraction of main flavonoids from Flos Sophorae Immaturus and evaluation of its extraction kinetics | |
Li et al. | Recent discovery of tyrosinase inhibitors in traditional Chinese medicines and screening methods | |
CN102988667A (zh) | 一种调经活血片的制备方法及应用 | |
Xu et al. | Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays | |
Chang et al. | Simultaneous determination of ten active components in traditional Chinese medicinal products containing both Gegen (Pueraria lobata) and Danshen (Salvia miltiorrhiza) by high‐performance liquid chromatography | |
CN105758950A (zh) | 基于量效色卡的气滞胃痛颗粒抗炎镇痛质量控制方法 | |
Li et al. | Influence of gastrointestinal digestion and edible plant combination on oral bioavailability of triterpene saponins, using a biomimetic digestion and absorption system and determination by HPLC | |
CN108956800B (zh) | 牡丹皮中鞣花酸含量的测定方法 | |
Li et al. | The quantitative comparative analysis for main bio-active components in Angelica sinensis, Ligusticum chuanxiong, and the herb pair Gui-Xiong | |
CN102539599B (zh) | 一种强肝药物的检测方法 | |
CN102100736A (zh) | 一种同时提取中药丹参中水溶性和脂溶性有效成分的方法 | |
CN102988480A (zh) | 一种胆香鼻炎片的制备方法及应用 | |
CN103245687B (zh) | 一种丹参注射液的基于组分结构的质量控制检测方法 | |
Lin et al. | Simultaneous determination of furostanol, pennogenyl, and diosgenyl glycosides in Taiwanese Rhizoma Paridis (Paris formosana Hayata) by high-performance liquid chromatography with evaporative light scattering detection | |
Dai et al. | Simultaneous determination of multiple constituents, serum composition, and tissue distribution of Qingshen granule using ultra‐high performance liquid chromatography‐quadrupole‐orbitrap high‐resolution mass spectrometry | |
CN105044259A (zh) | 一种用于检测含有大黄和/或番泻叶的制剂中的番泻苷类物质的方法 | |
CN102397346B (zh) | 一种乙肝扶正胶囊的制备方法 | |
CN105738499A (zh) | 精制冠心片特征图谱的构建和6种成分的测定方法 | |
CN103301291A (zh) | 桂圆益气补血汤及其制备方法和质量检测方法 | |
CN102759589B (zh) | 一种归丹沙棘胶囊中二苯乙烯苷与丹酚酸b的同时定量方法 | |
CN102988881B (zh) | 一种通脉灵片的制备方法及应用 | |
Zhang et al. | Determining the Levels of Four Phenylethanoid Glycosides and Five Triterpene Acids in Liuwei Dihuang Capsule Using Solid Phase Extraction with HPLC‐UV |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160922 Address after: 100039 Fengtai District West Fourth Ring Road, Beijing, No. 100 Applicant after: 302 MILITARY HOSPITAL OF CHINA Applicant after: China Medico Corp. Address before: 100039 Fengtai District West Fourth Ring Road, Beijing, No. 100 Applicant before: 302 Military Hospital of China |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 100039, No. 100 West Fourth Ring Road, Beijing, Fengtai District Patentee after: THE FIFTH MEDICAL CENTER OF THE CHINESE PEOPLE'S LIBERATION ARMY GENERAL Hospital Patentee after: China Medico Corp. Address before: 100039, No. 100 West Fourth Ring Road, Beijing, Fengtai District Patentee before: 302 MILITARY HOSPITAL OF CHINA Patentee before: China Medico Corp. |
|
CP03 | Change of name, title or address |